Search

Your search keyword '"Uhlig, H"' showing total 615 results

Search Constraints

Start Over You searched for: Author "Uhlig, H" Remove constraint Author: "Uhlig, H"
615 results on '"Uhlig, H"'

Search Results

2. DOP55 High diagnostic accuracy of 4-probe methylation biomarkers in paediatric Inflammatory Bowel Disease by epigenome-wide analysis

3. P570 Efficacy and safety of Adalimumab in Very Early-onset IBD- A Multicentre Study from the Paediatric IBD Porto Group of ESPGHAN

4. A protein-truncating R179X variant in RNF186 confers protection against ulcerative colitis.

6. Bottom-up synthesis of de-functionalized and dispersible carbon spheres as colloidal adsorbent

8. DOP02 Single cell RNA sequencing of Ulcerative Colitis and Crohn's Disease tissue samples informs the selection of Triggering Receptors Expressed on Myeloid Cells 1 (TREM1) as a target for the treatment of Inflammatory Bowel Diseases

10. Author Correction: Somatic mosaicism and common genetic variation contribute to the risk of very-early-onset inflammatory bowel disease (Nature Communications, (2020), 11, 1, (995), 10.1038/s41467-019-14275-y)

12. Automated annotator: capturing expert knowledge for free

17. Clinical genomics for the diagnosis of monogenic forms of inflammatory bowel disease

18. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)

19. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)

21. Cells of the human intestinal tract mapped across space and time

26. NOX1 loss-of-function genetic variants in patients with inflammatory bowel disease

27. Janus kinase inhibition for autoinflammation in DNASE2 deficiency

28. The short chain fatty acid butyrate imprints an antimicrobial program in macrophages

29. Local order of polymer derived amorphous SixCyNz

37. B cell epitopes of gliadin

38. Vedolizumab in Pediatric inflammatory bowel diseases: a retrospective multi-center experience from the paediatric IBD Porto group of ESPGHAN

39. Bacterial handling defect in macrophages of patients with defects in glucose-6-phosphate metabolism and Crohn's disease like intestinal inflammation

40. TrueColours ulcerative colitis (TCUC): Will patients with UC complete digital questionnaires in real-time?

41. Development of an index that predicts escalation of therapy at an outpatient appointment in patients with known ulcerative colitis (UC)

42. Can daily SCCAI measurements over a 6-month period better phenotype the pattern of disease in ulcerative colitis?

43. New faecal calprotectin cut-off points for remission and active disease defined by UCEIS and Nancy indices in ulcerative colitis (UC)

44. Should extraintestinal manifestations (EIMs) be part of disease activity assessment in ulcerative colitis?

Catalog

Books, media, physical & digital resources